Top of this page
Skip navigation, go straight to the content Newsroom UCB U.S. News


  • ICYMI: UCB in the News


    At UCB, we strive to discover and deliver new solutions patients value. Whether it’s through leveraging big data, thinking outside the box to overcome barriers, or collaborating with others in the healthcare industry—initiatives across UCB are at the forefront of research, and recently, our experts have been in the news talking about what we’re working on.

    Read more

  • Announcing the 2018 UCB Family Epilepsy Scholarship Winners


    UCB is pleased to announce 32 recipients were awarded the 2018 UCB Family Epilepsy Scholarship. This year’s winners are beginning their academic year at 31 schools across the country where awards will support their undergraduate or graduate education. Hailing from 17 states, this diverse group of passionate advocates includes people living with epilepsy or caregiving for someone living with epilepsy, including parents and siblings.

    Read more

  • Where is She Now? Reflections from UCB’s First Scholarship Winner

    Posted by


    As one of the first winners of the UCB Family Epilepsy Scholarship, Maria reflects on the goals, choices, and experiences that have shaped her ever-evolving career in science.

    Read more

  • The Day Psoriasis Stopped Stopping Me

    Posted by


    As part of Psoriasis Action Month, Alisha Bridges, an award-winning writer and community advocate, recently shared her story about living with psoriasis.

    Read more

  • UCB Runners Lace Up to Support Patients


    UCB supports local events across the country that benefit patients. Recently, our employees participated in two different runs in support of the epilepsy and Crohn’s disease communities.

    Read more

  • Press Release: FDA Accepts New Drug Application (NDA) to review Midazolam Nasal Spray, an investigational product for the acute treatment of seizure clusters


    FDA Accepts New Drug Application (NDA) to review Midazolam Nasal Spray, an investigational product for the acute treatment of seizure clusters

    Read more

  • New Resource for Those Living with Spondyloarthritis

    Posted by


    An estimated 3.3 million individuals in the U.S. are living with spondyloarthritis1,2 (SpA), an inflammatory disease affecting the spine, and in some people, the joints of the arms and legs, skin, intestines, and eyes. An underdiagnosed condition, most people with SpA first experience symptoms in their 20s or 30s but typically wait as many as 10 years between symptom onset and SpA diagnosis. *

    Read more

  • Disease Spotlight: Psoriasis


    August is Psoriasis Awareness Month so we’re shining a spotlight on the disease and how UCB is working to deliver solutions that patients value.

    Read more

  • Resources for Traveling with a Chronic Illness


    At UCB, we strive to support patients to live their best lives possible, and we know getting time away from home for summer vacation or other travel needs is part of life. Whether you live with a chronic illness, are a caregiver for someone who lives with a chronic illness, or not - traveling can be stressful. However, for many people living with a chronic illness, special considerations are needed during travel, and it can be particularly challenging when you must travel with medicines. Fortunately, with a little planning, you can decrease the hassle, reduce your stress, and enjoy your trip.

    Read more

  • UCB Hosts Wake County Teachers for STEM Immersion Program


    Yesterday, July 19, UCB’s Research Triangle Park (RTP) office hosted ten high school teachers as part of WakeEd’s SummerSTEM immersion program. SummerSTEM is an award-winning, eight-day professional development program to enrich educators’ understanding of the knowledge and skills necessary to succeed in STEM (Science, Technology, Engineering, & Math) careers. This program is a collaboration between the WakeEd Partnership, the Wake County Public School System, and biotech businesses in North Carolina.

    Read more